Follow

Biosergen AS

Nasdaq First North GM (Sweden)

Biosergen is a No-Research-Development-Only biotechnology company that employs all its organisational and financials resources on the clinical development of BSG005. BSG005 is a potentially disruptive antifungal drug with blockbuster potential based on significant safety and potency advantages over competing antifungals, including Amphotericin B, in more than a decade of preclinical studies.

Sector:
HEALTH CARE
 
News
20 May 2016 - 23:00
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
BSG
SE0016013460
Nasdaq First North GM
Sweden (SE)
Details of share in Biosergen AS with ticker BSG
Status
Inactive
Order book id
Amount of instruments
Par value
Currency
SEK
First trading date
24 Jun 2021
Type
Price
Pre-money
Time
Files
IPO
10.00 SEK
231.02M SEK
21 May - 04 Jun 2021
IPO in Biosergen AS
Type
Ticker
ISIN
Market
OPTION
BSG TO1
SE0016013478
Nasdaq First North GM
Sweden (SE)
Details of option in Biosergen AS with ticker BSG TO1
Status
Inactive
Order book id
Amount of instruments
Currency
SEK
First trading date
24 Jun 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 20.
Type
Price
Pre-money
Time
Files
Exercise
20.00 SEK
30 May - 10 Jun 2022
Option exercise terms for BSG TO1
People
Peder Møller Andersen
CEO
Torsten Rüdiger Goesch
Chairman of the board
Lena Degling
Board member
Achim Kaufhold
Board member
Marianne Kock
Board member
Henrik Moltke
Board member
Hanne Mette Dyrlie Kristensen
Board member
Mattias Klintemar
Board member
Company Details
Sector
HEALTH CARE

Address
Vestre Rosten 81
Zip code
7075
City/district
Trondheim
Country
Norway (NO)
Phones
Registration number
987 622 075
LEI code
549300C2ME54NKQH5J59
First trade date
24 Jun 2021
Registration date
23 Dec 2004
Short name
Biosergen

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More